Opportunity to make a difference, but unstable work environment - Mitarbeiter (anonym) bei Merck: Mitarbeiterbewertung

3,0
14. Sept. 2012
Mitarbeiter (anonym)
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

- Merck makes important medicines, such as its pediatric and adult vaccines. Manufacturing these medicines, and developing new medicines, is an important public health contribution. - Merck's strength is its organizational experience with clinical development and the regulatory environment, and in manufacturing of complicated medicines. - Lots of good experience to be had, in a variety of functional roles from discovery to development and manufacturing, from quality to regulatory to technical science and engineering jobs.

Kontras

Merck is trying to re-invent itself as a low-cost manufacturer, and leader of the field, but all while minimizing the amount of money spent. Upper management turnover is quite high, and leads to a very unstable environment, with a high rate of change, and minimal acknowledgement of the challenges this brings. The implicit message is that employees should be happy to have a job, and they should suck it up and work harder.

Mehr Bewertungen zu Merck entdecken

5,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Excellent company to work with.

Kontras

No cons encountered so far

4,0
30. Juni 2026
Empfehlen
CEO-Befürwortung
Geschäftsprognose

Pros

Great benefits like medical/dentist/vision, pension, stock option, 401k match. Co workers are excellent, pretty good on site symposiums, lot of diversity clubs/activities. Innovation is extremely welcomed. Diversity in research portfolio. AI/ML is heavily invested to make databases more efficient.

Kontras

Micro managing, especially within the biologics department, potentially others. Promotions are limited, and pay bump is poor. Company invests too much in buying companies rather than keeping talent - lay offs let go of great talented people. Merck is afraid of investing into exploratory biology and doesn’t take risk - they even admit they would rather see other companies clinical data or R&D data rather than taking a risk. Although it’s slow going in building new software, current databases are slow and needs much improvement. Extremely poor work/life balance.

Bewertungen anzeigen nach: Hilfreich|Sterne|Datum|Alle